Newsletter | January 25, 2023

01.25.23 -- Cell & Gene Sponsors: How Can You Help Your CDMO Help You?

New Podcast Episode
From The Editor
Featured Editorial
Industry Insights
MAM Solutions For Process And Product Control Of Biotherapeutic Proteins

With industry-leading scientific expertise and customer support, we have pioneered solutions to some of the most pressing challenges facing customers interested in adopting MAM into their organizations.

Addressing The Challenge Of Scalability In Viral Vectors

Learn more about a wide range of solutions to facilitate the delivery of gene therapy by addressing the challenges related to viral vector manufacture and scale-up.

Standardizing Viral Vector Manufacturing, Producer Cell Line Development

The TRiP System allows suppression of transgene expression during upstream processes, resulting in enhanced vector yield and purity, simplifying downstream processes.

How The inSeption Group Cooperativity Program Quickly Built A Client’s Medical Writing Team

The Cooperativity Program’s goal is to help ISG clients build and strengthen their in-house departments — medical writing or otherwise — to reach their utmost potential.

Adherent Versus Suspension Processes For Viral Vector Manufacturing

In adherent cell culture, cells are grown while attached to a substrate as monolayers. In suspension cell culture, cells are free-floating in the culture medium. Which offers more benefits?

mRNA Manufacturing Workflow

Therapies based on messenger RNA, such as mRNA vaccines, have revolutionary potential. Learn more about key objectives, considerations, and strategies in mRNA manufacturing.

Outsourced Pharma Live

Available On Demand! Throughout the year, chief editor Louis Garguilo brings together industry experts to discuss some of the biggest challenges being faced by both sponsors and CDMOs. Our archived videos can be accessed at any time by registered site users.